miR-205 Targets PTEN and PHLPP2 to Augment AKT Signaling and Drive Malignant Phenotypes in Non-Small Cell Lung Cancer

Cancer Research - United States
doi 10.1158/0008-5472.can-13-0297
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

miR-1269b Drives Cisplatin Resistance of Human Non-Small Cell Lung Cancer via Modulating the PTEN/PI3K/AKT Signaling Pathway

OncoTargets and Therapy
OncologyPharmacology
2020English

Dual Roles of miR-374a by Modulated C-Jun Respectively Targets CCND1-inducing PI3K/AKT Signal and PTEN-suppressing WNT/Β-Catenin Signaling in Non-Small-Cell Lung Cancer

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2018English

Hsa-miR-326 Targets CCND1 and Inhibits Non-Small Cell Lung Cancer Development

Oncotarget
Oncology
2016English

miR-181 Regulates Cisplatin-Resistant Non-Small Cell Lung Cancer via Downregulation of Autophagy Through the PTEN/PI3K/AKT Pathway

Oncology Reports
MedicineCancer ResearchOncology
2018English

ZNF259 Inhibits Non-Small Cell Lung Cancer Cells Proliferation and Invasion by FAK-AKT Signaling

Cancer Management and Research
Oncology
2017English

PAQR3 Inhibits Proliferation via Suppressing PI3K/AKT Signaling Pathway in Non-Small Cell Lung Cancer

Archives of Medical Science
Medicine
2018English

Role of miR‑520b in Non‑small Cell Lung Cancer

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2018English

miR-154 Suppresses Non-Small Cell Lung Cancer Growth in Vitro and in Vivo

Oncology Reports
MedicineCancer ResearchOncology
2015English

Mir‑106a Regulates Cell Proliferation and Apoptosis of Colon Cancer Cells Through Targeting the PTEN/PI3K/AKT Signaling Pathway

Oncology Letters
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy